Meru Capital Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-26,400
Closed -$2.68M 45
2015
Q4
$2.68M Sell
26,400
-110,128
-81% -$12.4M 0.83% 18
2015
Q3
$24.4M Sell
136,528
-21,517
-14% -$5.02M 6.36% 5
2015
Q2
$35.1M Sell
158,045
-23,000
-13% -$5.1M 7.57% 1
2015
Q1
$36M Buy
181,045
+22,995
+15% +$4.08M 8.19% 1
2014
Q4
$22.6M Buy
158,050
+58,450
+59% +$7.86M 7.32% 2
2014
Q3
$13.1M Sell
99,600
-27,400
-22% -$3.27M 4.7% 2
2014
Q2
$16M Buy
127,000
+12,000
+10% +$1.53M 4.51% 6
2014
Q1
$15.2M Buy
115,000
+10,000
+10% +$1.37M 3.96% 6
2013
Q4
$12.3M Sell
105,000
-34,190
-25% -$3.75M 2.64% 14
2013
Q3
$14.5M Buy
139,190
+106,466
+325% +$10.4M 3.63% 9
2013
Q2
$2.82M Buy
+32,724
New +$2.58M 0.53% 46

Other funds holding BHC

Meru Capital Group's BHC Position: Q1 2016 in Review

Meru Capital Group sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 26,400 shares — an estimated $2.68M sold.

Meru Capital Group first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $36M in Q1 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Meru Capital Group reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Meru Capital Group sold 26,400 Bausch Health shares in Q1 2016, an estimated $2.68M.
  • Meru Capital Group first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
  • Meru Capital Group's Bausch Health position peaked at $36M in Q1 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Meru Capital Group's 13F filing for Q1 2016, filed 13 May 2016.